knowledge and experience in the treatment of a wide variety of tumor types. IBA intends to utilize this expertise by collaborating with AEHL to offer a training and education program workshop to prospective proton treatment users in Asia and other regions of the world.
Olivier Legrain, Chief Executive Officer at IBA, expressed delight over the collaboration. He said, “Over recent years, Apollo Hospitals has shown its expertise and enthusiasm by successfully organizing training symposia for the local and international proton therapy experts’ community. We look forward to collaborating with Apollo in order to provide high-quality training and education to our customers and prospects in Asia without them traveling to another continent.” Dr. Prathap C Reddy, Founder and Chairman of Apollo Hospitals Enterprise Ltd, expressed optimism over the partnership. He said, “An acute need for high-quality cancer care, coupled with an increasing prevalence of cancer cases in India, led to the creation of Apollo Cancer Centers (ACC) around three decades ago. Since then, ACC has continually introduced the finest and most advanced cancer care into India, with the most recent being bringing Proton Therapy to the region. Furthermore, in keeping with its resolute mission to raise the bar in cancer care for all in need, in association with IBA, the Apollo Proton Cancer Center will be the first of its kind training and education program reference center in Asia”.
